Get Started Today As the demand for GLP-1 medications continues to grow, now is the time to explore how a direct-to-consumer prescription program can enhance your service offerings and meet the evolving needs of your patients
The trial included 80 people randomized to 0.1 mg of semaglutide, 78 to 0.2 mg, 82 to 0.4 mg, and 80 to placebo [3]
Interactions with other medications: Some medications, in combination with Rybelsus, may contribute to vision problems
Its suggested response is a provider conversation about holding the current dose longer, increasing gradually, or reviewing adherence and lifestyle factors
MeAgain keeps your symptoms, cycle notes, meals, hydration, weight trend, and weekly shot in one app, so the question of what changed after starting a GLP-1 gets answered with dates instead of guesses by you and by the clinician who knows your history
And about 20 percent maintained their weight loss